Median, 25th and 75th percentile multiples from disclosed pharmacy transactions, 2018-2026, by deal size (enterprise value). Cells need at least 10 deals.
| Deal size | Multiple | Median | P25 | P75 | Deals |
|---|---|---|---|---|---|
| $25M-100M | EV/Revenue | 1.68x | 0.78x | 4.29x | 22 |
| $100M-500M | EV/EBITDA | 13.30x | 11.02x | 15.00x | 11 |
| $100M-500M | EV/Revenue | 2.16x | 1.46x | 4.79x | 12 |
| >$500M | EV/EBITDA | 18.90x | 12.02x | 20.82x | 18 |
| >$500M | EV/Revenue | 1.30x | 0.39x | 5.95x | 13 |
Smaller deals usually trade at lower multiples than platform-sized ones, so compare a business with the row for its own size.
Pharmacy deal benchmarks on ExitValue.ai · How pharmacy businesses are valued
Estimate a specific business: free valuation calculator (full disclosure: built by the publisher of this dataset).
Open data, CC-BY-4.0. Aggregate medians of disclosed M&A transactions (licensed M&A database, SEC EDGAR filings, verified press releases). Published by ExitValue.ai · source repo · DOI 10.5281/zenodo.20398222